Skip to content
healthcare.dev

Duratuss AC

NDC 50991-540, Codeine Phosphate, Dexbrompheniramine Maleate, liquid, from Poly Pharmaceuticals, Inc..

Product NDC
50991-540
Status
Listed
Labeler
Poly Pharmaceuticals, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50991-540 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CODEINE PHOSPHATE10 mg/5mL
  • DEXBROMPHENIRAMINE MALEATE1 mg/5mL

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
50991-540-1650991054016473 mL in 1 BOTTLE (50991-540-16)
50991-540-205099105402020 mL in 1 BOTTLE (50991-540-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50991-540 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50991-540 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50991-540. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.